Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Milestone Pharmaceuticals Inc. (MIST)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Cash flows used in operating activities          
Net loss    -62.1-61.8-44.3-42.9-75.9-73.7
   
Adjustments to reconcile net loss to net cash used in operating activities:          
    Depreciation of property and equipment    0.10.10.10.10.20.2
    Share-based compensation expense    8.98.58.07.310.29.6
    Changes in operating assets and liabilities:          
        Other receivables    -0.30.00.00.1  
        Research and development tax credits receivable    0.10.40.40.4  
        Prepaid expenses    0.94.02.21.1-4.1-3.0
        Accounts payable and accrued liabilities    0.4-1.0-1.20.6-2.4-2.1
            Net cash used in operating activities    -52.0-49.8-34.7-33.2-71.6-69.5
   
Cash provided by (used in) investing activities          
Acquisition of property and equipment    -0.2-0.1    
Acquisition of short-term investments    -62.9-38.0-23.0   
Redemption of short-term investments    38.0  85.090.056.0
    Net cash provided by (used in) investing activities    -25.114.950.070.0-15.0-62.0
   
Cash provided by financing activities          
Proceeds from exercise of options    0.30.30.20.10.3 
Proceeds from employee stock purchase plan     0.20.0   
    Cash provided by financing activities    3.00.35.15.178.2103.0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy